Skip to Main Content

I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2)

Conditions

Breast - Female

Phase II

What is the purpose of this trial?

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learning more about which early indicators of response (tumor analysis prior to surgery via magnetic resonance imaging (MRI) images along with tissue and blood samples) are predictors of treatment success.

  • Trial with
    QuantumLeap Healthcare Collaborative
  • Start Date
    05/20/2018
  • End Date
    11/30/2020
Trial Image

For more information about this study, contact:

Anna Joseph

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

  • Last Updated
    06/01/2018
  • Study HIC
    #2000020575